Skip to content

CROSSER® CRUS106Recalls & reported problems

Bard Peripheral Vascular, Inc. · CROSSER® CTO Recanalization Catheter 14S, Rapid Exchange, 106cm · Class 2

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10801741125635), received between Mar 7, 2017 and Jan 24, 2025 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Device-Device Incompatibility” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device-Device Incompatibility2
  • Material Separation2
  • Detachment of Device or Device Component1
  • Failure to Advance1

Patient problems

  • No Consequences Or Impact To Patient2
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 24, 2025Material Separation; Device-Device Incompatibility; Material Separation; Device-Device Incompatibility

    IT WAS REPORTED THAT DURING A RECANALIZATION PROCEDURE, THE CATHETER WAS ALLEGEDLY STICK TO THE WIRE. IT WAS FURTHER REPORTED THAT THE WIRE ACCESS WAS LOST WHILE TRYING TO RETRIEVE THE DEVICE. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21231529 ↗
  • MalfunctionMar 20, 2017Material Separation; Failure to Advance; Device-Device Incompatibility; Material Separation; Failure to Advance; Device-Device Incompatibility

    IT WAS REPORTED THAT DURING TREATMENT IN THE ANTERIOR TIBIAL THE RECANALIZATION CATHETER ALLEGEDLY COULD NOT ADVANCE TO THE TARGET LESION; THEREFORE, THE HEALTH CARE PROVIDER REMOVED IT, AND UPON REMOVAL, THE RECANALIZATION CATHETER ALLEGEDLY BECAME STUCK ON THE GUIDEWIRE. THEREFORE, THE CATHETER AND GUIDEWIRE WERE REMOVED AS ONE UNIT. REPORTEDLY, ANOTHER WIRE AND CATHETER WERE USED THROUGH THE SAME ACCESS SITE TO COMPLETE THE PROCEDURE. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6419679 ↗
  • MalfunctionMar 7, 2017Detachment of Device or Device Component; Detachment of Device or Device Component

    IT WAS REPORTED THAT DURING USE IN A HEAVILY CALCIFIED OCCLUSION IN THE LEFT ILIAC, AFTER APPROXIMATELY THIRTY SECONDS OF ACTIVATION, THE DISTAL TIP OF THE RECANALIZATION CATHETER ALLEGEDLY DETACHED. IT WAS FURTHER REPORTED THAT THE DETACHED TIP WAS RETRIEVED USING A SNARE. ANOTHER CATHETER WAS USED TO PERFORM THE PROCEDURE, RESULTING IN VESSEL PATENCY WITH GOOD BLOOD FLOW. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6386195 ↗

Other Catheter for crossing total occlusions devices

All Catheter for crossing total occlusions devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.